IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell Carcinoma and Correlates With Poor Prognosis

被引:8
作者
Inoue, Masazumi [1 ]
Takeuchi, Hiroya [2 ]
Matsuda, Sachiko [1 ]
Nishi, Tomohiko [1 ]
Fukuda, Kazumasa [1 ]
Nakamura, Rieko [1 ]
Takahashi, Tsunehiro [1 ]
Wada, Norihito [1 ]
Kawakubo, Hirofumi [1 ]
Kitagawa, Yuko [1 ]
机构
[1] Keio Univ, Sch Med, Dept Surg, Tokyo, Japan
[2] Hamamatsu Univ, Sch Med, Dept Surg, Shizuoka, Japan
关键词
Oesophageal squamous cell carcinoma; IL-8; CXCR2; chemokine; cell proliferation; WNT ANTAGONIST SFRP1; PHASE-III TRIAL; CXCR2; EXPRESSION; POSTOPERATIVE COMPLICATIONS; GASTROESOPHAGEAL JUNCTION; PREOPERATIVE CHEMOTHERAPY; EPIGENETIC INACTIVATION; CANCER; GROWTH; INTERLEUKIN-8;
D O I
10.21873/anticanres.14830
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: The inflammatory cytokine IL-8 and its receptor CXCR2 are key signalling pathway molecules in cancer development. We hypothesized that IL-8/CXCR2 signalling promotes tumour progression in oesophageal squamous cell carcinoma (ESCC) patients. Materials and Methods: We examined the relationship between IL-8/CXCR2 expression and clinicopathological factors by inununohistochemistry in samples from 63 patients with resectable ESCC. The effects of IL-8/CXCR2 signalling on cell proliferation and gene expression were examined in vitro and in vivo using ESCC cell lines. Results: Increased IL-8/CXCR2 signalling was associated with shorter overall survival (p<0.05) and recurrence-free survival (p<0.05) in ESCC patients. Multivariate analysis identified IL-8/CXCR2 expression as a prognostic factor for surgically treated ESCC (p<0.05). In vitro, IL-8 exposure or over-expression significantly enhanced ESCC cell proliferation. SB225002, a CXCR2-specific antagonist, and IL-8 siRNA significantly suppressed cell proliferation. Conclusion: IL-8/CXCR2 expression is an independent prognostic factor for surgically treated ESCC, and IL-8/CXCR2 signalling contributes to ESCC cell proliferation.
引用
收藏
页码:783 / 794
页数:12
相关论文
共 34 条
[1]   Interleukin-8 in cancer pathogenesis, treatment and follow-up [J].
Alfaro, Carlos ;
Sanmamed, Miguel F. ;
Rodriguez-Ruiz, Maria E. ;
Teijeira, Alvaro ;
Onate, Carmen ;
Gonzalez, Alvaro ;
Ponz, Mariano ;
Schalper, Kurt A. ;
Perez-Gracia, Jose L. ;
Melero, Ignacio .
CANCER TREATMENT REVIEWS, 2017, 60 :24-31
[2]   Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years [J].
Ando, N ;
Ozawa, S ;
Kitagawa, Y ;
Shinozawa, Y ;
Kitajima, M .
ANNALS OF SURGERY, 2000, 232 (02) :225-232
[3]   A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907) [J].
Ando, Nobutoshi ;
Kato, Hoichi ;
Igaki, Hiroyasu ;
Shinoda, Masayuki ;
Ozawa, Soji ;
Shimizu, Hideaki ;
Nakamura, Tsutomu ;
Yabusaki, Hiroshi ;
Aoyama, Norio ;
Kurita, Akira ;
Ikeda, Kenichiro ;
Kanda, Tatsuo ;
Tsujinaka, Toshimasa ;
Nakamura, Kenichi ;
Fukuda, Haruhiko .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (01) :68-74
[4]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550
[5]   Wnt signaling: a common theme in animal development [J].
Cadigan, KM ;
Nusse, R .
GENES & DEVELOPMENT, 1997, 11 (24) :3286-3305
[6]   The Wnt antagonist sFRP1 in colorectal tumorigenesis [J].
Caldwell, GM ;
Jones, C ;
Gensberg, K ;
Jan, S ;
Hardy, RG ;
Byrd, P ;
Chughtai, S ;
Wallis, Y ;
Matthews, GM ;
Morton, DG .
CANCER RESEARCH, 2004, 64 (03) :883-888
[7]   Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen α (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2 [J].
Catusse, J ;
Liotard, A ;
Loillier, B ;
Pruneau, D ;
Paquet, JL .
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (05) :813-821
[8]   CXCR2 antagonists for the treatment of pulmonary disease [J].
Chapman, R. W. ;
Phillips, J. E. ;
Hipkin, R. W. ;
Curran, A. K. ;
Lundell, D. ;
Fine, J. S. .
PHARMACOLOGY & THERAPEUTICS, 2009, 121 (01) :55-68
[9]   Molecular mechanisms of the antitumor activity of SB225002: A novel microtubule inhibitor [J].
Goda, Ahmed E. ;
Koyama, Makoto ;
Sowa, Yoshihiro ;
Elokely, Khaled M. ;
Yoshida, Tatsushi ;
Kim, Bo-Yeon ;
Sakai, Toshiyuki .
BIOCHEMICAL PHARMACOLOGY, 2013, 85 (12) :1741-1752
[10]   Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma [J].
Huang, Jian ;
Zhang, Yun-Li ;
Teng, Xiao-Mei ;
Lin, Yun ;
Zheng, Da-Li ;
Yang, Peng-Yuan ;
Han, Ze-Guang .
BMC CANCER, 2007, 7 (1)